|
|
|
| Evaluation of drug treatment of acute attack of gout in one patient with diabetic nephropathy caused by Aspirin combined with Furosemide |
| CHENG Xi1 JIANG Xuehua2 LONG Enwu3 KE Hong1 |
1.Department of Pharmacy, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Sichuan Province, Chengdu 610072, China;
2.West China School of Pharmacy, Sichuan University, Sichuan Province, Chengdu 610041, China;
3.Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Sichuan Province, Chengdu 610072, China |
|
|
|
Abstract Long term diabetes patients are often associated with a variety of diseases, the choice of therapeutic drugs need to be comprehensively considered. Clinical pharmacists participate in the whole process of diagnosis and treatment of one patient with diabetic nephropathy, in combination with renal function, pay close attention to drug interactions. To the acute attack of gout caused by Aspirin combined with Furosemide, clinical pharmacists timely intervene and adjust the drug treatment program to ensure the safety and effectiveness of medication. The patient was given correct medication and lifestyle guidance, so that the blood sugar levels and gout symptoms were well controlled, and the compliance of the patient was improved. Clinical pharmacists give full play to their professional advantages, optimize treatment plan to assist the doctors, and play an important role in rational drug use.
|
|
|
|
|
|
[1] Madero M，Samak MJ，Wang X，et al. Uric acid and long-term out-comes in CKD [J]. Am J Kidney Dis，2009，53（5）：796-803.
[2] Bo S，Cavallo-Perin P，Gentile L，et al. Hypouricemia and hyperuricemia in type 2 diabetes：two different phenotypes [J]. Eur J Clin Invest，2001，31（4）：318-321.
[3] 中国医师协会内分泌代谢科医师分会.2型糖尿病合并慢性肾脏病口服降糖药用药原则中国专家共识（2015年更新版）[J].中华内分泌代谢杂志，2016，32（6）：455.
[4] 上海慢性肾脏病早发现及规范化诊治与示范项目专家组.慢性肾脏病筛查诊断及防治指南[J].中国实用内科杂志，2017，37（1）：28-29.
[5] 高尿酸血症相关疾病诊疗多学科共识专家组.中国高尿酸血症相关疾病诊疗多学科专家共识[J].中华内科杂志，2017，56（3）：241.
[6] Caspi D，Lubart E，Graff E，et al. The effect of mini-dose aspirin on renal function and uric acid handing in elderly patients [J]. Arthritis Rheummatism，2000，43（1）：103-108.
[7] 张海英，卓来东，李玉珍.小剂量阿司匹林对正常小鼠及高尿酸血症模型小鼠血尿酸的影响[J].中国新药杂志，2009，18（5）：434-436.
[8] 李俊.临床药理学[M].5版.北京：人民卫生出版社，2013：420-421.
[9] Walsem AV，Pandhi S，Nixon RM，et al. Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis：a network meta-analysis [J]. Arthritis Res Ther，2015，17（1）：1-18.
[10] Patricia MG，David H. Cardiovascular risk with non-steroidal anti-inflammatory drugs：systematic review of population-based controlled observational studies [J]. PLoS Med，2011，8（9）：e1001098.
[11] 中华医学会风湿病学分会.2016中国痛风诊疗指南[J].中华内科杂志，2016，55（11）：893.
[12] Richette P，Doherty M，Pascual E，et al. 2016 updated EULAR evidence-based recommendations for the management of gout [J]. Ann Rheum Dis，2017，76（1）：29-42.
[13] 中国医师协会肾脏内科医师分会.中国肾脏疾病高尿酸血症诊治的实践指南（2017版）[J].中华医学杂志，2017， 97（25）：1930.
[14] 中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组.中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2014[J].中华神经科杂志，2015，48（4）：262-263.
[15] Ringleb PA，Bhatt DL，Hirsch AT，el al. Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events [J]. Stroke，2004，35（2）：528-532.
[16] Bhatt DL，Marso SP，Hirsch AT，et al. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus [J]. Am J Cardiol，2002，90（6）：625-628.
[17] 母义明，郭代红，彭永德，等.临床药物治疗学内分泌代谢疾病[M].北京：人民卫生出版社，2017：445.
[18] Chrysostomou A，Becker G. Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease [J]. N Engl J Med，2001，345（12）：925-926.
[19] 万青松，谢红萍，杨波.安体舒通联合氢氯噻嗪对2型糖尿病肾病蛋白尿的影响[J].中国现代医学杂志，2015， 25（5）：57-60.
[20] 缪逸，朱建琴.非布司他治疗痛风的临床效果研究[J].中国现代医生，2016，54（26）：103-105.
[21] 中华医学会内分泌学分会.中国成人住院患者高血糖管理目标专家共识[J].中华内分泌代谢杂志，2013，29（3）：189. |
|
|
|
